Pharmaceutical Chemistry

Regional Ayurveda Research Institute (RARI), Gwalior established in the year 1970, is engaged in research with the focused mandate 1. Human Resource Development Activities and 2. Ayurveda Drug Development. The out-patient department of the Institute caters the primary health needs of the patients reporting for different illnesses, out of which the patients are registered for research programs allocated from time to time. The Institute is equipped with 25 bedded In-patient Department, a well equipped laboratory for biochemical and pathological investigations.

The Vallabhbhai Patel Chest Institute (VPCI) is a unique postgraduate medical institution devoted to the study of chest diseases. It is a University of Delhi maintained institution and is funded entirely by the Ministry of Health and Family Welfare, Government of India. The institute is ideally located in the heart of the main campus of the University of Delhi, providing the requisite academic environment. The Institute fulfills the national need for providing relief to large number of patients in the community suffering from chest diseases.

Indian Institute of Technology Jodhpur was established in 2008, to foster technology education and research in India. The Institute is committed to technological thought and action to benefit the economic development of India. Scholarship in teaching and learning; Scholarship in research and creative accomplishments; and relevance to Industry are three driving forces for us at IIT Jodhpur.

Natco Pharma Limited was incorporated in Hyderabad in the year 1981 with an initial investment of INR 3.3 million. With a modest beginning of operations as a single unit with 20 employees, Natco today has five manufacturing facilities spread across India with dedicated modern research laboratories, capabilities in New Drug Development, etc.

Post : Chemist / Executive / Officer

CSIR-Central Drug Research Institute, Lucknow, a premier Institute under Council of Scientific and Industrial Research (CSIR), is involved in multidisciplinary R&D programs of both basic and applied nature. CSIR-CDRI is a pioneer biomedical research organization in India and has the infrastructure and expertise to develop a drug from concept to commercialization. In the year 2012, CSIR-CDRI shifted to its state of the art new campus, which has been set up with a vision to serve as a Nodal Center of CSIR in new drug discovery and development.

Maharashtra Public Service Commission is an Autonomous Body constituted and set up under Article 315 of the Constitution of India to discharge the duties and functions as assigned under Article 320 of the Constitution. The Commission accordingly recommends suitable candidates for the various posts under the Government and advises Government on various service matters like formulation of recruitment rules, on promotions, transfers, and disciplinary proceedings, etc.

Translational Health Science and Technology Institute (THSTI) is an autonomous Institute of the Department of Biotechnology, Ministry of Science and Technology, Govt. of India. The institute is an integral part of the interdisciplinary NCR Biotech Science Cluster located at Faridabad, and is designed as a dynamic, interactive organization with the mission to conduct innovative translational research and to develop research collaborations across disciplines and professions to translate concepts into products to improve human health.

Sun Pharmaceutical Industries Ltd. (Sun Pharma) is the fourth largest specialty generic pharmaceutical company in the world with global revenues of over 5 billion usd. Supported by more than 40 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.

Indian Pharmacopoeia Commission (IPC) is an Autonomous Institution of the Ministry of Health and Family Welfare, Govt. of India. IPC is created to set standards of drugs in the country. Its basic function is to update regularly the standards of drugs commonly required for treatment of diseases prevailing in this region. It publishes official documents for improving Quality of Medicines by way of adding new and updating existing monographs in the form of Indian Pharmacopoeia (IP).